Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including one oral presentation, have ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

Pharming Group N.V. ("Pharming” or "the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following ...

Iksuda Therapeutics (Iksuda), the developer of class leading, clinically validated antibody drug conjugates (ADCs) today announces that it will present three posters at the American Association for ...